We narrowed to 1,380 results for: ABE8e
-
Plasmid#182058PurposePlasmids for production of LV-based TFactivity reporterDepositorInsertRep5 and Ref5
UseLentiviralPromotersynthetic minimal promoterAvailable sinceMarch 23, 2022AvailabilityAcademic Institutions and Nonprofits onlyCited by -
pLVTFrep3-creb
Plasmid#182056PurposePlasmids for production of LV-based TFactivity reporterDepositorInsertRep3 and Ref3
UseLentiviralPromotersynthetic minimal promoterAvailable sinceMarch 23, 2022AvailabilityAcademic Institutions and Nonprofits onlyCited by -
pLVTFrep1-creb
Plasmid#182054PurposePlasmids for production of LV-based TFactivity reporterDepositorInsertRep1 and Ref1
UseLentiviralPromotersynthetic minimal promoterAvailable sinceMarch 23, 2022AvailabilityAcademic Institutions and Nonprofits onlyCited by -
E1_pENTR_L1-L4_NI_G1333-DddtoxA-C
Plasmid#171724PurposeptpTALECD vector assembly, Entry clone 1 with attL1 and L4DepositorInsertC- and N-termini of TALEN, half of cytidine deaminase domain of dddA of Burkholderia cenocepacia, uracil glycosylase inhibitor
UseMultisite gateway entry vectorAvailable sinceJuly 29, 2021AvailabilityAcademic Institutions and Nonprofits onlyCited by -
E1_pENTR_L1-L4_NN_G1333-DddtoxA-C
Plasmid#171728PurposeptpTALECD vector assembly, Entry clone 1 with attL1 and L4DepositorInsertC- and N-termini of TALEN, half of a cytidine deaminase domain of dddA of Burkholderia cenocepacia, uracil glycosylase inhibitor
UseMultisite gateway entry vectorAvailable sinceJuly 29, 2021AvailabilityAcademic Institutions and Nonprofits onlyCited by -
E3_pENTR_L3-L2_NG_G1333-DddtoxA-C
Plasmid#171732PurposeptpTALECD vector assembly, Entry clone 1 with attL2 and L3DepositorInsertC- and N-termini of TALEN, half of cytidine deaminase domain of dddA of Burkholderia cenocepacia, uracil glycosylase inhibitor
UseMultisite gateway entry vectorAvailable sinceJuly 29, 2021AvailabilityAcademic Institutions and Nonprofits onlyCited by -
E1_pENTR_L1-L4_NI_G1333-DddtoxA-N
Plasmid#171725PurposeptpTALECD vector assembly, Entry clone 1 with attL1 and L4DepositorInsertC- and N-termini of TALEN, half of cytidine deaminase domain of dddA of Burkholderia cenocepacia, uracil glycosylase inhibitor
UseMultisite gateway entry vectorAvailable sinceJuly 29, 2021AvailabilityAcademic Institutions and Nonprofits onlyCited by -
E1_pENTR_L1-L4_NN_G1333-DddtoxA-N
Plasmid#171729PurposeptpTALECD vector assembly, Entry clone 1 with attL1 and L4DepositorInsertC- and N-termini of TALEN, half of cytidine deaminase domain of dddA of Burkholderia cenocepacia, uracil glycosylase inhibitor
UseMultisite gateway entry vectorAvailable sinceJuly 29, 2021AvailabilityAcademic Institutions and Nonprofits onlyCited by -
E3_pENTR_L3-L2_NG_G1333-DddtoxA-N
Plasmid#171733PurposeptpTALECD vector assembly, Entry clone 1 with attL2 and L3DepositorInsertC- and N-termini of TALEN, half of cytidine deaminase domain of dddA of Burkholderia cenocepacia, uracil glycosylase inhibitor
UseMultisite gateway entry vectorAvailable sinceJuly 27, 2021AvailabilityAcademic Institutions and Nonprofits onlyCited by -
pYPQ265C
Plasmid#164715PurposeGateway entry clone (attL1 & attR5) hAID-CBE_V01 for C-T base editingDepositorInserthAID-zCas9(D10A)-UGI
UseCRISPR; Gateway compatible haid-cbe_v01 entry clo…ExpressionPlantAvailable sinceMay 21, 2021AvailabilityAcademic Institutions and Nonprofits onlyCited by -
pYPQ265E1
Plasmid#164718PurposeGateway entry clone (attL1 & attR5) A3A-CBE_V01 for C-T base editingDepositorInsertA3A-zCas9(D10A)-UGI
UseCRISPR; Gateway compatible a3a-cbe_v01 entry cloneExpressionPlantAvailable sinceMay 21, 2021AvailabilityAcademic Institutions and Nonprofits onlyCited by -
pYPQ265E3
Plasmid#164720PurposeGateway entry clone (attL1 & attR5) eA3A-CBE_V01 for C-T base editingDepositorInserteA3A-zCas9(D10A)-UGI
UseCRISPR; Gateway compatible ea3a-cbe_v01 entry clo…ExpressionPlantAvailable sinceMay 21, 2021AvailabilityAcademic Institutions and Nonprofits only -
BE3-YE1
Plasmid#132943PurposeGene editing. See Gene/Insert section of plasmid page for targeting sequence cloned into this plasmid.DepositorInsertBE3-(W90Y-R126E)
UseCRISPR; Base editorExpressionMammalianMutationBE3-(W90Y-R126E)Available sinceNov. 24, 2020AvailabilityAcademic Institutions and Nonprofits only -
nSaCas9 P742 miniABEMax V82G
Plasmid#135385PurposeExpression of nSaCas9 intradomain insertion of single evolved TadA monomer (V82G) at the specified position (P742 )DepositorInsertnSaCas9 P742 miniABEMax V82G
UseCRISPRExpressionMammalianMutation(V82G)Available sinceOct. 1, 2020AvailabilityAcademic Institutions and Nonprofits only -
nSaCas9 Q731 miniABEMax V82G
Plasmid#135386PurposeExpression of nSaCas9 intradomain insertion of single evolved TadA monomer (V82G) at the specified position (Q731 )DepositorInsertnSaCas9 Q731 miniABEMax V82G
UseCRISPRExpressionMammalianMutation(V82G)Available sinceOct. 1, 2020AvailabilityAcademic Institutions and Nonprofits only -
nSaCas9 Q737 miniABEMax V82G
Plasmid#135387PurposeExpression of nSaCas9 intradomain insertion of single evolved TadA monomer (V82G) at the specified position (Q737 )DepositorInsertnSaCas9 Q737 miniABEMax V82G
UseCRISPRExpressionMammalianMutation(V82G)Available sinceOct. 1, 2020AvailabilityAcademic Institutions and Nonprofits only -
nSaCas9 S740 miniABEMax V82G
Plasmid#135388PurposeExpression of nSaCas9 intradomain insertion of single evolved TadA monomer (V82G) at the specified position (S740 )DepositorInsertnSaCas9 S740 miniABEMax V82G
UseCRISPRExpressionMammalianMutation(V82G)Available sinceOct. 1, 2020AvailabilityAcademic Institutions and Nonprofits only -
nSaCas9 T128 miniABEMax V82G
Plasmid#135389PurposeExpression of nSaCas9 intradomain insertion of single evolved TadA monomer (V82G) at the specified position (T128 )DepositorInsertnSaCas9 T128 miniABEMax V82G
UseCRISPRExpressionMammalianMutation(V82G)Available sinceOct. 1, 2020AvailabilityAcademic Institutions and Nonprofits only -
nSaCas9 D127 miniABEMax V82G
Plasmid#135366PurposeExpression of nSaCas9 intradomain insertion of single evolved TadA monomer (V82G) at the specified position (D127 )DepositorInsertnSaCas9 D127 miniABEMax V82G
UseCRISPRExpressionMammalianMutation(V82G)Available sinceOct. 1, 2020AvailabilityAcademic Institutions and Nonprofits only -
nSaCas9 D126 miniABEMax V82G
Plasmid#135367PurposeExpression of nSaCas9 intradomain insertion of single evolved TadA monomer (V82G) at the specified position (D126 )DepositorInsertnSaCas9 D126 miniABEMax V82G
UseCRISPRExpressionMammalianMutation(V82G)Available sinceOct. 1, 2020AvailabilityAcademic Institutions and Nonprofits only